TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/25 14:30 | 1/15/25 | AVIR | Atea Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | MA | D | P.am | 81 | 3.26 | 0 | 25 | 6 | 477 | D | |||||||||||||||
1/17/25 08:03 | 1/15/25 | AVIR | Atea Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | MA | D | P.m | 81 | 3.26 | 0 | 25 | 6 | 477 | D | |||||||||||||||
11/22/23 18:22 | 11/21/23 | EPIX | Essa Pharma Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | A1 | D | P | 133 | 5.73 | 0 | 23 | 3 | 784 | D | |||||||||||||||
11/16/23 17:45 | 11/2/23 | EPIX | Essa Pharma Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | A1 | D | P.m | 420 | 5.49 | 0 | 76 | 11 | 761 | D | |||||||||||||||
11/23/22 17:45 | 11/21/22 | RAIN | Rain Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | CA | D | P.m | 988 | 8.10 | 0 | 122 | 14 | 1,005 | D | |||||||||||||||
11/14/22 16:17 | 11/8/22 | RAIN | Rain Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Berger Franklin M | CA | D | P | 250 | 5.83 | 0 | 43 | 5 | 883 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |